Cases & Deals

  • Home
  • Practices
  • Celgene enters into strategic collaboration with Quanticel to develop cancer drugs

Share

Celgene enters into strategic collaboration with Quanticel to develop cancer drugs

November 2011

Client(s) Celgene Corporation

Jones Day assisted Celgene Corporation in a strategic collaboration with Quanticel Pharmaceuticals Inc. to discover and develop first-in-class cancer drugs including the acquisition of an equity stake and an exclusive option to acquire Quanticel.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.